Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Chronic Kidney Disease Market Growth in 2025?

The market size for chronic kidney disease has seen a formidable growth in the latter years. The escalation is projected to go from $70.65 billion in 2024 to $75.09 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.3%. Factors fuelling this growth rate during the historical timeframe include the rise in hypertension and diabetes, an aging demographic, unhealthy lifestyle habits, healthcare accessibility issues and advances made in the medical field.

What Is the Forecast for the Chronic Kidney Disease Market Size Through 2029?

The market size of chronic kidney disease is anticipated to experience robust growth in the coming years, reaching $95.85 billion by 2029 with a compound annual growth rate (CAGR) of 6.3%. This expected growth within the forecasted period can be related to healthcare policy priorities, advancements in precision medicine, an increasing obesity rate, rise in chronic diseases, and better healthcare accessibility. Major future trends entail early detection campaigns, telemedicine and remote patient monitoring, patient strengthening programs, community-centric care efforts, and the incorporation of nutritional therapy.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

What are the Key Market Players in Chronic Kidney Disease Market and How They’re Evolving?

Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

What Are the Primary Growth Drivers in the Chronic Kidney Disease Market?

The surge in kidney disease cases is poised to bolster the expansion of the chronic kidney disease market. Encompassing a variety of conditions impacting the kidneys’ operation and structure, kidney diseases necessitate medication for controlling patients’ blood pressure and reducing protein loss. This is done in order to inhibit kidney deterioration, handle symptoms, and prevent side effects. As per the Centers for Disease Control and Prevention, a national public health agency in the US, it was reported that in July 2022, around 15%, or 37 million US citizens, suffered from kidney disease. As a result, the escalating incidence of kidney disease is fuelling the expansion of the chronic kidney disease market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

What Are the Leading Segments in the Global Chronic Kidney Disease Industry?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Are the Key Market Trends in the Chronic Kidney Disease Industry?

A key trend that’s gaining traction in the chronic kidney disease market is the innovation of products. To maintain their market stature, companies in this arena are creating inventive products. For example, Bayer, a biotechnology and pharmaceutical firm based in Germany, unveiled the innovative medication Kerendia (finerenone) in August 2022. This new drug is designed to slow down the progression of chronic kidney disease among diabetic patients. It stands out as a first-of-its-kind non-steroidal, selective mineralocorticoid receptor antagonist that is distinct from current treatments. Its main function is to block overactivation of the mineralocorticoid receptor (MR), which plays a key role in advancing CKD and causing cardiovascular damage.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

What Is the Regional Outlook for the Chronic Kidney Disease Market?

North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969

This Report Delivers Insight On:

1. How big is the chronic kidney disease market, and how is it changing globally?

2. Who are the major companies in the chronic kidney disease market, and how are they performing?

3. What are the key opportunities and risks in the chronic kidney disease market right now?

4. Which products or customer segments are growing the most in the chronic kidney disease market?

5. What factors are helping or slowing down the growth of the chronic kidney disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model